SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4

ANTONIO D'AVOLIO; Alessia CIANCIO; MARCO SICCARDI; LORENA BAIETTO; MARCO SIMIELE; Samantha Patanella; Diego Aguilar Marucco; Giuseppe Cariti; Andrea CALCAGNO; Mauro SCIANDRA; Antonina SMEDILE; Francesco Giuseppe DE ROSA; Stefano BONORA; Mario RIZZETTO; Giovanni DI PERRI

SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4

ANTONIO D'AVOLIO
, Alessia CIANCIO
, MARCO SICCARDI
, LORENA BAIETTO
, MARCO SIMIELE
, Samantha Patanella
, Diego Aguilar Marucco
, Giuseppe Cariti
, Andrea CALCAGNO
, Mauro SCIANDRA
, Antonina SMEDILE
, Francesco Giuseppe DE ROSA
, Stefano BONORA
, Mario RIZZETTO
, Giovanni DI PERRI

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo alla conferenza › Abstract › peer review

Lingua originale	Inglese
Pagine	S463-S463
Numero di pagine	1
Stato di pubblicazione	Pubblicato - 2010
Evento	45th Annual Meeting of the European-Association-for-the-study-of-the-liver - Vienna, Austria Durata: 1 gen 2010 → …

???event.eventtypes.event.conference???

???event.eventtypes.event.conference???	45th Annual Meeting of the European-Association-for-the-study-of-the-liver
Città	Vienna, Austria
Periodo	1/01/10 → …

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Accesso al documento

https://hdl.handle.net/11579/216792

Altri file e collegamenti

handle

Cita questo

D'AVOLIO, ANTONIO., CIANCIO, A., SICCARDI, MARCO., BAIETTO, LORENA., SIMIELE, MARCO., Patanella, S., Marucco, D. A., Cariti, G., CALCAGNO, A., SCIANDRA, M., SMEDILE, A., DE ROSA, F. G., BONORA, S., RIZZETTO, M., & DI PERRI, G. (2010). SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4. S463-S463. Abstract da 45th Annual Meeting of the European-Association-for-the-study-of-the-liver, Vienna, Austria. https://hdl.handle.net/11579/216792

@conference{2f754ceb60ce47be952a15d52115976f,

title = "SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4",

author = "ANTONIO D'AVOLIO and Alessia CIANCIO and MARCO SICCARDI and LORENA BAIETTO and MARCO SIMIELE and Samantha Patanella and Marucco, \{Diego Aguilar\} and Giuseppe Cariti and Andrea CALCAGNO and Mauro SCIANDRA and Antonina SMEDILE and \{DE ROSA\}, \{Francesco Giuseppe\} and Stefano BONORA and Mario RIZZETTO and \{DI PERRI\}, Giovanni",

year = "2010",

language = "English",

pages = "S463--S463",

note = "45th Annual Meeting of the European-Association-for-the-study-of-the-liver ; Conference date: 01-01-2010",

}

D'AVOLIO, ANTONIO, CIANCIO, A, SICCARDI, MARCO, BAIETTO, LORENA, SIMIELE, MARCO, Patanella, S, Marucco, DA, Cariti, G, CALCAGNO, A, SCIANDRA, M, SMEDILE, A, DE ROSA, FG, BONORA, S, RIZZETTO, M & DI PERRI, G 2010, 'SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4', 45th Annual Meeting of the European-Association-for-the-study-of-the-liver, Vienna, Austria, 1/01/10 pagg. S463-S463. <https://hdl.handle.net/11579/216792>

SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4. / D'AVOLIO, ANTONIO; CIANCIO, Alessia; SICCARDI, MARCO et al.
2010. S463-S463 Abstract da 45th Annual Meeting of the European-Association-for-the-study-of-the-liver, Vienna, Austria.

Risultato della ricerca: Contributo alla conferenza › Abstract › peer review

TY - CONF

T1 - SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4

AU - D'AVOLIO, ANTONIO

AU - CIANCIO, Alessia

AU - SICCARDI, MARCO

AU - BAIETTO, LORENA

AU - SIMIELE, MARCO

AU - Patanella, Samantha

AU - Marucco, Diego Aguilar

AU - Cariti, Giuseppe

AU - CALCAGNO, Andrea

AU - SCIANDRA, Mauro

AU - SMEDILE, Antonina

AU - DE ROSA, Francesco Giuseppe

AU - BONORA, Stefano

AU - RIZZETTO, Mario

AU - DI PERRI, Giovanni

PY - 2010

Y1 - 2010

UR - https://iris.uniupo.it/handle/11579/216792

M3 - Abstract

SP - S463-S463

T2 - 45th Annual Meeting of the European-Association-for-the-study-of-the-liver

Y2 - 1 January 2010

ER -

D'AVOLIO ANTONIO, CIANCIO A, SICCARDI MARCO, BAIETTO LORENA, SIMIELE MARCO, Patanella S et al.. SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4. 2010. Abstract da 45th Annual Meeting of the European-Association-for-the-study-of-the-liver, Vienna, Austria.